Biggest News Aggregation in the World
📰 Matt Rettig News

Matt Rettig News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Matt Rettig. Real-time updates on events, politics, business and more.

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune in Patients with Metastatic Castration-Resistant Prostate Cancer

02.01.2024 - Boca Raton, Florida, Jan. 02, 2024 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight  disease, dosed ... Seite 1
Boca Raton United States Matt Rettig University Of California Jonsson Comprehensive Cancer Center David Geffen School Of Medicine

INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune™, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer

Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 --... | May 8, 2023
David Moss Inmune Bio Jason Nelson Mark Lowdell Matt Rettig Inmune Biocontact

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science